• Nie Znaleziono Wyników

Left ventricular aneurysm in hypertrophic cardiomyopathy with midventricular obstruction

N/A
N/A
Protected

Academic year: 2022

Share "Left ventricular aneurysm in hypertrophic cardiomyopathy with midventricular obstruction"

Copied!
2
0
0

Pełen tekst

(1)

KARDIOLOGIA POLSKA 2020; 78 (5) 474

Histological examination of the obtained spec‑

imens showed hypertrophied cardiomyocytes with signs of hibernation and necrosis in the an‑

eurysmal wall, which confirmed the diagno‑

sis of HCM. The patient was prescribed lifelong treatment with beta ‑blockers.

The midventricular obstructive form of HCM accounts for 9.4% of cases of hypertrophic car‑

diomyopathy.1,2 Midventricular obliteration in systole leads to 2‑chamber (hourglass) appear‑

ance of the LV, which consists of basal and api‑

cal chambers.1 Continuous‑wave Doppler echo‑

cardiography shows a paradoxical jet between 2 chambers: systolic flow from the apical cham‑

ber to the basal one interrupts in mid ‑systole, and then continues in late systole and early dias‑

tole due to relief of obstruction.3 LVAA is present in up to 28.3% of patients with midventricular obstruction.1 While midventricular obstruction is an independent risk factor for sudden death, apical aneurysm poses the risk of arrhythmia and embolic stroke.2

Left ventricular apical aneurysm in HCM should be differentiated from postinfarction aneurysm, LV diverticulum, cardiac sarcoid‑

osis, myocarditis, Behçet disease, and Chagas disease. It is a common complication after myo‑

cardial infarction, associated with a particu‑

larly difficult decision ‑making process regard‑

ing treatment.4 Presence of midventricular ob‑

struction helps to differentiate between mid‑

ventricular HCM and other causes of aneurysm formation.1 Coronary angiography is needed to rule out ischemic heart disease. Cardiac com‑

puted tomography has the advantage of pre‑

cise assessment of LV morphology and wall thickness, as well as simultaneous evaluation of the coronary arteries. Contrast ‑enhanced We report a case of a patient with left ventricu‑

lar apical aneurysm (LVAA), caused by midven‑

tricular hypertrophic cardiomyopathy (HCM).

A 64‑year ‑old man was admitted to the hospital with a suspicion of postinfarction LVAA. The pa‑

tient had transient ischemic attack 2 months before the admission. Cerebral magnetic res‑

onance imaging revealed multiple cerebral in‑

farctions, probably of embolic origin. During examination aimed to detect the cardiac source of embolism, LVAA was revealed. Electrocardi‑

ography demonstrated signs of left ventricu‑

lar (LV) hypertrophy with strain. Echocardiog‑

raphy (Philips XI XP, Philips Healthcare, Eind‑

hoven, The Netherlands) showed normal LV sys‑

tolic function, hypertrophy of the midventric‑

ular segments, and near ‑complete obliteration of the LV chamber during systole (hourglass configuration; FIGURE 1A; Supplementary materi‑

al, Video S1). Continuous‑wave Doppler echo‑

cardiography showed an apical ‑to ‑basal gradi‑

ent of 36 mm Hg in the LV cavity in systole and early diastole (FIGURE 1B). We found an apical out‑

pouching in the LV, which was connected with the LV apical chamber through a narrow neck.

This was consistent with the diagnosis of LVAA due to midventricular HCM (FIGURE 1C; Supplemen‑

tary material, Video S2 and S3). Coronary angi‑

ography did not show any lesions in the coro‑

nary arteries. Cardiac computed tomography (Toshiba Aquilion 128 TSX‑101A, Toshiba Med‑

ical System, Ōtawara, Tochigi, Japan) demon‑

strated midventricular hypertrophy with ob‑

struction of flow in systole and LVAA reminis‑

cent of a 3‑leaf clover in shape, without clots in‑

side (FIGURE 1D and 1E). Aneurysmectomy was per‑

formed because of high risk of cerebral embolic stroke due to thrombus formation in the LVAA.

Correspondence to:

Nelya Oryshchyn, MD, PhD,  Diagnostic Radiology  Department, Danylo Halytsky  Lviv National Medical University,  Pekarska 69, Lviv, 79010, Ukraine,  phone: +38 032 275 76 32,  email: oryshchyn_n@yahoo.com Received: February 29, 2020.

Revision accepted:

March 18, 2020.

Published online: March 19, 2020.

Kardiol Pol. 2020; 78 (5): 474-475 doi:10.33963/KP.15243 Copyright by the Author(s), 2020

C L I N I C A L V I G N E T T E

Left ventricular aneurysm in hypertrophic

cardiomyopathy with midventricular obstruction

Nelya Oryshchyn1,2, Yuriy Ivaniv1

1  Diagnostic Radiology Department, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine 2  Lviv Regional Centre of Cardiology, Lviv, Ukraine

(2)

C L I N I C A L V I G N E T T E Left ventricular aneurysm in hypertrophic cardiomyopathy 475

HOW TO CITE Oryshchyn N, Ivaniv Y. Left ventricular aneurysm in hyper- trophic cardiomyopathy with midventricular obstruction. Kardiol Pol. 2020; 78: 

474-475. doi:10.33963/KP.15243

REFERENCES

1  Minami Y, Kajamoto K, Terajima Y, et al. Clinical implications of midventric- ular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardi- ol. 2011; 57: 2346-2355.

2  Xiao Y, Wang L, Yang Y, et al. Clinical profile and prognosis of left ventricu- lar apical aneurysm in hypertrophic cardiomyopathy. Am J Med Sci. 2016; 351: 

101-110.

3  Nakamura T, Matsubara K, Furukawa K, et al. Diastolic paradoxic jet flow in  patients with hypertrophic cardiomyopathy: evidence of concealed apical asyner- gy with cavity obliteration. J Am Coll Cardiol. 1992; 19: 516-524.

4  Bednarek A, Wieczorek J, Elżbieciak M, Mizia -Stec K. Treatment strategies for  a giant left ventricular aneurysm and developing ventricular septal defect in a pa- tient after anterior wall myocardial infarction. Kardiol Pol. 2020; 78: 86-88.

5  Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic cardiomyopathy with left ven- tricular apical aneurysm: implications for risk stratification and management. J Am  Coll Cardiol. 2017; 69: 761-773.

cardiac magnetic resonance imaging allows clinicians to evaluate LV geometry and the ex‑

tent of myocardial fibrosis.5 Treatment rec‑

ommendations for the management of HCM with apical aneurysm are scarce. Implantable cardioverter ‑defibrillator insertion and life long anticoagulation should be considered. The deci‑

sion to perform aneurysmectomy depends on the risk of developing systemic embolism and arrhythmia.1,4

SUPPLEMENTARY MATERIAL

Supplementary material is available at www.mp.pl/kardiologiapolska.

ARTICLE INFORMATION

CONFLICT OF INTEREST None declared.

OPEN ACCESS This is an Open Access article distributed under the terms  of  the  Creative  Commons  Attribution -Non  Commercial -No  Derivatives  4.0  In- ternational License (CC BY -NC -ND 4.0), allowing third parties to download ar- ticles and share them with others, provided the original work is properly cited,  not changed in any way, distributed under the same license, and used for non- commercial purposes only. For commercial use, please contact the journal office  at kardiologiapolska@ptkardio.pl.

FIGURE 1 A – echocardiography, apical 2‑chamber view: midventricular hypertrophy with obstruction of the left ventricular cavity in systole (arrow);

B – Doppler echocardiography showing the systolic midventricular gradient (white arrow) and the diastolic gradient (red arrow) between the basal and apical left ventricular chambers; C – echocardiography, apical long ‑axis view: apical aneurysm (arrow); D – contrast ‑enhanced cardiac computed tomography: apical aneurysm (arrow) and hypertrophic midventricular segments (asterisks); E – three ‑dimensional reconstruction of apical aneurysm (arrow) on cardiac computed tomography

A

C D E

B

*

*

Cytaty

Powiązane dokumenty

Resting echocardiography revealed significant left ventricular hypertrophy (interventricular septum, 21 mm; posterior wall, 14 mm), without LVOT obstruction at rest and

Further genetic studies should be performed to try to answer to the following question: are HCM and LVNC two overlapping diseases or two different manifestations of the

Lobna Laaroussi, Université Tunis El Manar, Faculté de Médecine de Tunis, Service de Cardiologie Hopital Abderrahmen Mami, 2008 Ariana, Tunisia, e-mail:

The relationship between circulating microRNAs and left ventricular mass in symptomatic heart failure patients with systolic dysfunction.. Baris Ikitimur 1 , Huseyin Altug Cakmak 1

3 Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznan, Poland.. Hypertrophic cardiomyopathy (HCM) is one of the most common heart

The following subjects were also excluded from this study: patients with diabetes mellitus, hypertension, severe morbid obesity [body mass index (BMI) > 35], stage > three

An increase in mean left atrial or LV end-diastolic pressure will result in a reduction of RUPV systol- ic velocity and therefore mean RUPV systolic ve- locity in patients with

In patients with heart failure and left ventricu- lar systolic dysfunction with impaired glucose to- lerance left ventricular diastolic dysfunction is more advanced and the